RupeestopAbout UsMutual Funds

Compiled by Rupeestop LLP, SEBI RIA INA000022701. NAV as on 19 Nov 2026. Factsheet Jun 2026. About · Disclosures

HDFC Pharma and Healthcare Fund Regular Growth

HDFC Mutual Fund
Sector HealthcareRegularGrowth
NAV

₹22.664

As on 19 Nov 2026

Vs category

PeriodThis fundCategoryRank
1 year+30.13%——
3 year+28.92%——
5 year+30.06%——

HDFC Mutual Fund

Returns

From NAVs through 19 Nov 2026

1Y
+30.13%
Total
3Y
+28.92%
p.a.
5Y
+30.06%
p.a.
SI
+30.06%
p.a.

Calendar years

+13.64%
2023
+50.33%
2024
+1.22%
2025
+31.54%
2026 YTD

Rolling 1-year · 26 overlapping windows

+3.77%avg +23.68%+63.41%

Fund facts

Fund details from the Jun 2026 factsheet

Fund size
₹2362.44 Cr
Expense ratio
1.97%
Launched03 Oct 2023
ISININF179KC1HL7

Where the money is invested

Split by asset type.

By asset type

Equity98.70%
Cash1.30%

What the fund holds

35 holdings · portfolio as on 30 May 2026

  • Sun Pharmaceuticals Industries Ltd
    Healthcare
    9.2%
  • Divi's Laboratories Ltd
    Healthcare
    8.02%
  • Lupin Ltd
    Healthcare
    5.45%
  • Max Healthcare Institute Ltd Ordinary Shares
    Healthcare
    5.26%
  • Aster DM Healthcare Ltd Ordinary Shares
    Healthcare
    5.18%
  • Cipla Ltd
    Healthcare
    4.92%
  • Acutaas Chemicals Ltd
    Basic Materials
    4.5%
  • Alkem Laboratories Ltd
    Healthcare
    4.36%
  • Anthem Biosciences Ltd
    Healthcare
    4.15%
  • Ipca Laboratories Ltd
    Healthcare
    3.5%

Concentration

Top 5 weight
33.12%
Top 10 weight
54.55%
Avg turnover
43.33%

Risk and quality measures

How steady the returns have been.

Return quality

Sharpe
0.92
Better than category avg 0.48
Alpha
8.42
Return above the benchmark

Risk

Std deviation
16.32%
How much returns swing
Beta
1.04
Below category avg 0.94
R-squared
97.1%
How closely it tracks the benchmark

SIP illustration

Rate
+28.92%
Invested
₹6,00,000
Illustrated
₹34,89,875

₹5,000/mo × 10 years at this fund's 3Y CAGR. Illustration, not a forecast. SIP calculator

FAQ

What is HDFC Pharma and Healthcare Fund Regular Growth NAV today?

The latest NAV of HDFC Pharma and Healthcare Fund Regular Growth is ₹22.664 as on 19 Nov 2026.

How has HDFC Pharma and Healthcare Fund Regular Growth performed vs its category?

1-year return +30.13%. Past performance does not guarantee future returns.

What are the returns of HDFC Pharma and Healthcare Fund Regular Growth?

Trailing returns from published NAVs: 1 year +30.13%, 3 year +28.92% a year, 5 year +30.06% a year, since our first NAV +30.06% a year. Past performance does not guarantee future returns.

How would a SIP in HDFC Pharma and Healthcare Fund Regular Growth have been illustrated?

The SIP illustration on this page uses ₹5,000 a month for 10 years at this fund's 3-year annualised return of +28.92%. It is not a forecast.

What is the expense ratio and fund size of HDFC Pharma and Healthcare Fund Regular Growth?

For HDFC Pharma and Healthcare Fund Regular Growth, the expense ratio is 1.97% and fund size (AUM) is ₹2362.44 Cr.

What is the ISIN of HDFC Pharma and Healthcare Fund Regular Growth?

The ISIN for HDFC Pharma and Healthcare Fund Regular Growth is INF179KC1HL7.

Mutual fund investments are subject to market risks. Read all scheme related documents carefully before investing. Past performance does not guarantee future returns and is not an indicator of future results.

Figures on this page come from published NAVs and the scheme's monthly factsheet. They are for information only and are not investment advice or a recommendation to buy or sell any scheme.